XEME BIOPHARMA
XEME Biopharma Inc. is a clinical-stage company that offers services for developing therapeutic products under the guidance of the Food and Drug Administration (FDA) in the area of active cancer immunotherapy (vaccines). This area of therapeutic cancer vaccines is expected by many oncology specialists to provide the next breakthrough in the treatment of cancer beyond the current approaches of surgery, radiation, chemotherapy, and passive immunotherapy (monoclonal antibodies).
XEME BIOPHARMA
Industry:
Biopharma Biotechnology Health Care Medical Therapeutics
Founded:
2005-01-01
Address:
Monmouth Junction, New Jersey, United States
Country:
United States
Website Url:
http://www.xemebiopharma.com
Total Employee:
1+
Status:
Active
Contact:
+1 732 230 3124
Email Addresses:
[email protected]
Official Site Inspections
http://www.xemebiopharma.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.186
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "XEME Biopharma"
Milestones - xeme
January 2017: XEME launched a web-based investment portal (invest.xemebiopharma.com) to raise capital via S.E.C. Regulation D, 506 c mechanism (for Accredited Investors using …See details»
Management | xeme
Founder, Vice President Research, Development and Quality Assurance. Salvador Vargas, MD. International clinical oncology advisorSee details»
XEME Biopharma - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +1 732 230 3124 XEME Biopharma Inc. is a clinical-stage company that offers services for developing therapeutic products under the …See details»
XEME Biopharma Inc. - LinkedIn
XEME Biopharma Inc. | 142 followers on LinkedIn. XEME Biopharma Inc. is clinical-stage company focused on developing therapeutic products in the area of active cancer …See details»
XEME BIOPHARMA, INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for XEME BIOPHARMA, INC. of Monmouth Junction, NJ. Get the latest business insights from Dun & …See details»
XEME Biopharma - The Org
XEME Biopharma Inc. is a clinical-stage company focused on developing therapeutic products in the area of active cancer immunotherapy (vaccines). This area of therapeutic cancer vaccines …See details»
XEME Biopharma - Org chart - The Org
Explore XEME Biopharma's organizational chart. Discover current team members including executives, board members, and advisors.See details»
Xeme Biopharma, Inc. - Drug pipelines, Patents, Clinical trials
Last update 11 Jul 2024. Xeme Biopharma, Inc.See details»
Xeme Biopharma Company Profile | Management and Employees …
Xeme Biopharma Profile and History. At present, XEME Biopharma is focused on two integrated technology platforms: AGGREGONTM and Oncolipin. The AGGREGONTM technology is …See details»
XEME Biopharma - Products, Competitors, Financials, Employees ...
Headquarters Location. 1120 North DuPage Avenue . Lombard, Illinois, 60148, United States (844)709-9363See details»
Contact - xeme
Email : [email protected] Phone : 1.732.230.3124. Fax : 1.732.230.3150. Address : 7 Deerpark Dr. Ste M-1, Monmouth Junction, NJ 08852See details»
XEME Biopharma Inc. - Company Profile & Staff Directory
XEME Biopharma Inc. is clinical-stage company focused on developing therapeutic products in the area of active cancer immunotherapy (vaccines). This area of therapeutic cancer vaccines …See details»
Xeme Biopharma - Overview, News & Similar companies - ZoomInfo
Xeme Biopharma contact info: Phone number: (844) 709-9363 Website: www.xemebiopharma.com What does Xeme Biopharma do? At present, XEME Biopharma is …See details»
Xeme Biopharma - PitchBook
Xeme Biopharma General Information Description. Developer of therapeutic cancer vaccines designed to treat cancer. The company's vaccine activates the undamaged immune system of …See details»
XEME Biopharma Company Information - Funding, Investors, and …
Track over 71,000 companies. Discover Fast-growing Global startups. Seedtable uses technology and people to track over 71,000 companies to help you find the right ones to partner with.See details»
Investor Information - xeme
XEME is offering a Series A Preferred Stock will be sold in a private placement exempt from registration pursuant to Section 4(a)(2) and/or Rule 506(b) of the Securities Act of 1933, as …See details»
XEME Biopharma Inc. – Medium
Mar 28, 2018 Read writing from XEME Biopharma Inc. on Medium. XEME Biopharma Inc. is a clinical-stage company focused on developing therapeutic products in the area of active …See details»
Simplification for success: Rewiring the biopharma operating model
Mar 21, 2025 Thirty-seven of them expect their organization to pursue a simplification effort over the next 12 months. Thirty-two respondents say they believe they need a significantly different …See details»
Richard Robb - xeme
He has an extensive science managerial experience that comprises pre-clinical research, product development, toxicology studies, quality control /assurance and organization and monitoring of …See details»
Historical Perspective - xeme
Vaccines based on Aggregon® technology were shown to be highly effective in animal studies of lymphoma and melanoma conducted and published by the Founders and their collaborators.See details»